(S (NP (NP (DT The) (JJ main) (NN goal)) (PP (IN of) (NP (NNP Systems) (NNP Biology) (NN research)))) (VP (VBZ is) (S (VP (TO to) (VP (VB reconstruct) (NP (JJ biological) (NNS networks)) (PP (IN for) (NP (PRP$ its) (JJ topological) (NN analysis))) (SBAR (IN so) (IN that) (S (NP (JJ reconstructed) (NNS networks)) (VP (MD can) (VP (VB be) (VP (VBN used) (PP (IN for) (NP (NP (DT the) (NN identification)) (PP (IN of) (NP (NP (JJ various) (NNS kinds)) (PP (IN of) (NP (NN disease)))))))))))))))) (. .))
(S (NP (NP (DT The) (NN availability)) (PP (IN of) (NP (NP (JJ high-throughput) (NNS data)) (VP (VBN generated) (PP (IN by) (NP (NN microarray) (NNS experiments))))))) (VP (VBD fueled) (S (NP (NNS researchers)) (VP (VP (TO to) (VP (VB use) (NP (JJ whole-genome) (NN gene) (NN expression) (NNS profiles)) (S (VP (TO to) (VP (VB understand) (NP (NN cancer))))))) (CC and) (VP (TO to) (VP (VB reconstruct) (NP (JJ key) (JJ cancer-specific) (NN gene) (JJ regulatory) (NN network))))))) (. .))
(S (ADVP (RB Now)) (, ,) (NP (DT the) (NNS researchers)) (VP (VBP are) (VP (VBG taking) (NP (NP (DT a) (JJ keen) (NN interest)) (PP (IN in) (NP (NP (DT the) (NN development)) (PP (IN of) (NP (NP (NN algorithm)) (PP (IN for) (NP (NP (DT the) (NN reconstruction)) (PP (IN of) (NP (NN gene) (JJ regulatory) (NN network))) (PP (IN from) (NP (JJ whole) (JJ genome) (NN expression) (NNS profiles)))))))))))) (. .))
(S (PP (IN In) (NP (DT this) (NN study))) (, ,) (NP (NP (DT a) (JJ cancer-specific) (NN gene) (JJ regulatory) (NN network)) (PRN (-LRB- -LRB-) (NP (JJ prostate) (NN cancer)) (-RRB- -RRB-))) (VP (VBZ has) (VP (VBN been) (VP (VBN constructed) (S (VP (VBG using) (NP (DT a) (ADJP (JJ simple) (CC and) (JJ novel)) (ADJP (NNS statistics) (VBN based)) (NN approach))))))) (. .))
(S (ADVP (RB First)) (, ,) (NP (NP (JJ significant) (NNS genes)) (VP (ADVP (RB differentially)) (VBG expressing) (NP (PRP them) (PRP self)) (PP (IN in) (NP (DT the) (NN disease) (NN condition))))) (VP (VBZ has) (VP (VBN been) (VP (VBN identified) (S (VP (VBG using) (NP (NP (DT a) (NN two-stage) (VBG filtering) (NN approach)) (NP (JJ t-test) (CC and) (NX (JJ fold-change) (NN measure))))))))) (. .))
(S (ADVP (JJ Next)) (, ,) (NP (NP (JJ regulatory) (NNS relationships)) (PP (IN between) (NP (DT the) (VBN identified) (NNS genes)))) (VP (VBZ has) (VP (VBN been) (VP (VBN computed) (S (VP (VBG using) (NP (NNP Pearson) (NN correlation) (NN coefficient))))))) (. .))
(S (NP (DT The) (VBN obtained) (NNS results)) (VP (VBZ has) (VP (VBN been) (VP (VBN validated) (PP (IN with) (NP (DT the) (JJ available) (NNS databases) (CC and) (NN literature)))))) (. .))
(S (NP (PRP We)) (VP (VBD obtained) (NP (NP (DT a) (JJ cancer-specific) (JJ regulatory) (NN network)) (PP (IN of) (NP (CD 29) (NNS genes))) (PP (IN with) (NP (NP (DT a) (NN total)) (PP (IN of) (NP (CD 55) (JJ regulatory) (NNS relations))))) (SBAR (WHPP (IN in) (WHNP (WDT which))) (S (NP (NP (DT some)) (PP (IN of) (NP (DT the) (NNS genes)))) (VP (VBZ has) (VP (VBN been) (VP (VBN identified) (PP (IN as) (NP (NP (NN hub) (NNS genes)) (SBAR (WHNP (WDT that)) (S (VP (MD can) (VP (VB act) (PP (IN as) (NP (NP (NN drug) (NN target)) (PP (IN for) (NP (DT the) (NN cancer) (NN diagnosis)))))))))))))))))) (. .))
